Founded in 2001, TATAA Biocenter is world’s largest organizer of hands-on training in quantitative real-time PCR, Europe’s leading provider of nucleic acid analysis services, and leading developer of tools and technologies for nucleic acid analysis. TATAA is serving majority of world´s largest Pharmaceutical compa-nies, hundreds of innovative small enterprises and academic and government institutions. TATAA´s research-ers have published over 100 peer reviewed papers including the MIQE guidelines cited over 2000 times (Clinical Chemistry 55, 4, 2009) and produced 20 patents protecting technologies behind products currently on the diagnostic market. TATAA´s own portfolio covers more than 25 in-house developed products sold globally by TATAA and its distributors or through global companies based on licensing agreements.
TATAA’ main tasks in this project are to further develop methods to detect miRNA biomarkers and to open training courses for end-users.
Key persons:
Mikael Kubista, Ph.d., CEO
Role: WP-Leader of WP5.
Robert Sjöback, PhD, R&D manager, robert.sjoback@tataa.com
Role: Task Leader of Task 5.3.
www.tataa.com